Articles

ACC, HRS, SCAI, left atrial appendage occlusion, recommendations

The American College of Cardiology (ACC), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI) released a new overview on the implantation of left atrial...

HIMSS, survey, cybersecurity, cyberattacks, healthcare organizations, IT

Cybersecurity was identified as an increased business priority over the past year according to 87 percent of respondents in the newly released 2015 HIMSS (Healthcare Information and Management...

The American Society of Echocardiography (ASE) Annual Scientific Sessions is the premier echocardiographic professional conference. The ASE is an organization of professionals dedicated and...

MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue

New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients annually, according to a new paper. The...

A nationwide study published in the Journal of the American College of Cardiology identified current frequent barriers to cardio-oncology services in the United States. According to the...

fibrin, MSCs, stem cells, heart failure, Antoni Bayes-Genis, umbilical cord

To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for the patient’s body to reject the new...

Philips, Lumify, app-based ultrasound, transducer

Philips announced the introduction of Lumify, its first app-based ultrasound solution that will extend the reach of ultrasound applications across the health continuum using mobile...

defibrillators, older heart patients, Duke Medicine study, Tracy Wang

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the...

Medtronic, CoreValve Evolut R, FDA approval, TAVR, recapturable

Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the recapturable, self-expanding CoreValve Evolut R System. The first-and-only recapturable and...

cangrelor, Kangreal, FDA approval, The Medicines Company, antiplatelet agent

The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy to percutaneous coronary...